News-Blog

Warrants On Maple Gold Mines – Worth A Shot?

By Dudley Pierce Baker CommonStockWarrants.com Bob Moriarty , 321Gold.com, has written about Maple Gold Mines, TSXV:MGM on several occasions: Maple Gold for $6 an Ounce US and I was wrong about an Oct crash (October 31, 2019) Bob Moriarty Talks Gold, Irving, Novo, Maple Gold and More (October 8, 2019) Maple Gold for $3.02 an Ounce US (October 1, 2019) The share price is been really strong lately and the company just announced more advanced activity at their Douay property. “Maple Gold Mines Ltd. has engaged Computational Geosciences Inc. (CGI) to complete a new and expanded artificial intelligence study for targeting high-grade gold at Douay.” The question now, is it time to buy the shares or perhaps the stock warrants? Frequently overlooked by investors are stock warrants trading, if any, on their favorite companies. In this case, Maple Gold Mines does have stock warrants trading, TSXV:MGM.WT The exercise price is C$0.40 and the warrants will expire on June 27, 2022. If the shares continue to trade below C$0.40 through the expiration date the warrants are and will be worthless. However, what if, in the next two years Maple Gold has some great drill results and the shares skyrocket. This brings in the potential for outrageous gains with the additional leverage with the stock warrants.   A few projections for you: Projections for Common shares                   
  
.50             .60         .75          1.00         1.50 As of July 9, 2020 – C$0.17 Gain on shares      … Continue reading

Warrants On Maple Gold Mines – Worth A Shot? Read More »

Warrantless but not unwarranted: Therapeutics Acquisition prices first ever SPAC IPO of common shares

Note from Dudley Pierce Baker, CommonStockWarrants.com I just saw this article out today and wanted to share it will my followers. If you follow the SPAC’s, blank check companies, this is the first offering without a stock warrant. Only shares were issued, not units, and thus no warrants which we frankly love to see as they are included in our database. I kind of doubt this will become a trend but I will be watching. Warrantless but not unwarranted: Therapeutics Acquisition prices first ever SPAC IPO of common shares July 8, 2020 2020’s blank check boom hit another major milestone with Therapeutics Acquisition (TXAC). For the first time in their roughly 20-year history, a SPAC has completed an IPO by selling common shares rather than units, signaling ever-greater demand in the space. SPAC offerings normally include units consisting of shares of common stock and tradable warrants. Therapeutics Acquisition marks a notable first, but it is also part of a trend, with more SPACs this year lowering their warrant component to 1/3 and 1/4 warrants. 2020 SPAC milestones The first ever SPAC IPO of common shares: Therapeutics Acquisition (TXAC) The largest SPAC ever to go public: Churchill Capital Corp III (CCXXU) The largest SPAC ever to file for an IPO: Pershing Square Tontine (PSTH.U) The biggest quarter ever by proceeds (tied for most deals): 2Q20, 24 SPACs and $7.2 billion On pace for a record year in 2020 Several companies have chosen SPAC listings over IPOs   Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million … Continue reading

Warrantless but not unwarranted: Therapeutics Acquisition prices first ever SPAC IPO of common shares Read More »